Literature DB >> 1674870

Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor.

Y Morishita1, T Sano, K Ando, Y Saitoh, H Kase, K Yamada, Y Matsuda.   

Abstract

During the search for ANP receptor ligands of microbial origin, we isolated a novel polysaccharide, HS-142-1, from culture broth of Aureobasidium sp. HS-142-1 inhibited [125I]-rANP binding to ANP receptor in rabbit kidney cortex membranes with an IC50 of 0.3 mu g/ml, but gave no effects on specific binding of [125I]-Endothelin nor [125I]-Angiotensin II to their respective receptors in bovine lung membranes. HS-142-1 competitively and selectively inhibited ANP binding to its guanylyl cyclase-containing receptor purified from solubilized bovine adrenocortical membranes and blocked cGMP production elicited by ANP. HS-142-1 is the first non-peptide antagonist selective for ANP functional receptor and will be a powerful tool to elucidate the physiological functions of ANP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1674870     DOI: 10.1016/0006-291x(91)90374-g

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Natriuretic peptide receptors and heart failure: to B or not to B blocked?

Authors:  A J Hobbs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-12-06       Impact factor: 3.000

Review 2.  Interventions in the B-type natriuretic peptide signalling pathway as a means of controlling chronic itch.

Authors:  Jianghui Meng; Weiwei Chen; Jiafu Wang
Journal:  Br J Pharmacol       Date:  2020-02-12       Impact factor: 8.739

Review 3.  The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides.

Authors:  A M Richards
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

4.  Allotopic antagonism of the non-peptide atrial natriuretic peptide (ANP) antagonist HS-142-1 on natriuretic peptide receptor NPR-A.

Authors:  Hugo Poirier; Jean Labrecque; Julie Deschênes; André DeLéan
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

5.  Vasonatrin peptide, a new regulator of adiponectin and interleukin-6 production in adipocytes.

Authors:  B-Y Chen; R Tie; P Qu; M-Z Zhu; X-X Zhu; J Jin; J Yu
Journal:  J Endocrinol Invest       Date:  2011-05-17       Impact factor: 4.256

6.  Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.

Authors:  N Yokota; B G Bruneau; M L Kuroski de Bold; A J de Bold
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.

Authors:  Melanie Madhani; Ramona S Scotland; Raymond J MacAllister; Adrian J Hobbs
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

8.  Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor.

Authors:  Inmaculada C Villar; Catherine M Panayiotou; Adil Sheraz; Melanie Madhani; Ramona S Scotland; Muriel Nobles; Barbara Kemp-Harper; Amrita Ahluwalia; Adrian J Hobbs
Journal:  Cardiovasc Res       Date:  2007-03-03       Impact factor: 10.787

9.  Identification of renal natriuretic peptide receptor subpopulations by use of the non-peptide antagonist, HS-142-1.

Authors:  R A Rutherford; Y Matsuda; M R Wilkins; J M Polak; J Wharton
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

10.  Neutral endopeptidase 24.11 in neutrophils modulates protective effects of natriuretic peptides against neutrophils-induced endothelial cytotoxity.

Authors:  T Matsumura; K Kugiyama; S Sugiyama; M Ohgushi; K Amanaka; M Suzuki; H Yasue
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.